Aurobindo Pharma Limited
₹1,249
INR-0.45(-0.04%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹81611.39 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹83084.31 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
23.35
Forward P/E
Price to Earnings ratio based on forecasted earnings
22.56
PEG Ratio
Price/Earnings to Growth ratio
22.56
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.75
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
58.80%
Operating Margin
Operating income as a percentage of revenue
16.06%
Return on Equity
Net income as a percentage of shareholders' equity
10.63%
Revenue (TTM)
Total revenue over trailing 12 months
₹29718.37 Cr+10.5%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹6950.96 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹60.17+61.1%
Balance Sheet
Total Cash
Total cash and short-term investments
₹6326.36 Cr
Total Debt
Total short-term and long-term debt
₹6647.63 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
22.27%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹850.1 - ₹1592
Beta
Measure of stock's volatility compared to the market
0.53
Shares Outstanding
Total number of shares issued by the company
₹58.08 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.43%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
7.49%